CCRN Stock Analysis: Buy, Sell, or Hold?
CCRN - Cross Country Healthcare Inc
$13.13
0.01 (0.08%)
▲
5d:
+0.31%
30d:
+30.78%
90d:
+65.16%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Distribution
CCRN is up 23.1% this week, but smart money is buying puts. Top strike: $13 2026-06-18 with 7 OI. Put ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When CCRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CCRN is 10.1% above its trading range ($11.93). Market expects -9.7% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CCRN is 10.1% above its trading range ($11.93). Market expects -9.7% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$13.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$8.25
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CCRN is currently trading at $13.13, which is considered extended relative to its 30-day fair value range of $9.33 to $11.93. From a valuation perspective, the stock is trading at a discount (Forward PE: 48.1) compared to its historical average (65.4). Remarkably, the market is currently pricing in an annual earnings decline of 9.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CCRN is in a strong uptrend. The price is approaching resistance at $13.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CCRN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $11.62. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CCRN is in a strong uptrend. The price is approaching resistance at $13.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CCRN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $11.62. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.33 -
$11.93
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.9%
All Signals
- BEARISH: Price significantly overextended (+10.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 11.5% above Wall St target ($11.62)
Trading Range Analysis
30-Day Trading Range
$9.33 -
$11.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.06
Resistance Level
$13.18
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
48.11
Wall Street Target
$11.63
(-11.5%)
Revenue Growth (YoY)
-17.8%
Earnings Growth (YoY)
-78.5%
Profit Margin
-9.8%
Valuation Discount vs History
-9.7% cheaper
PE vs Historical
48.1 vs 65.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.7%
(market-implied from PE analysis)
1-Year Target
$11.86
(-10%)
2-Year Target
$10.71
(-19%)
3-Year Target
$9.67
(-26%)
3-Yr Target (if PE normalizes)
(PE: 48→65)
$13.14
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 48.1, Growth: 118.3%)
$44.31
(+238%)
Base:
(SPY PE: 22.0, Growth: 118.3%)
$20.30
(+55%)
Bear:
(PE: 18.7, Growth: 118.3%)
$17.25
(+31%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 48.1 to 65.4
Stabilization Target:
$17.85
(+35.9%)
PE Expansion Potential:
+35.9%
Share & Embed Analysis
Last updated: May 14, 2026 7:49 PM ET
Data refreshes hourly during market hours. Next update: 8:49 PM
Data refreshes hourly during market hours. Next update: 8:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 59 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |
